Takahiro Iwamiya
Metcela Inc, Japan
Biography
Takahiro Iwamiya has completed his PhD from Tokyo Women’s Medical University and Project Research Associate studies from Institute for Advanced Biosciences, Keio University. He is the Co-Founder & Co-CEO of Metcela Inc. He has published three patents and has been developing novel cell therapy products for heart failure patients.
Abstract
Abstract : Cardiac fibroblasts expressing VCAM-1 improve function recovery of the infarcted heart